In the last trading session, 4.69 million shares of the GSK Plc ADR (NYSE:GSK) were traded, and its beta was 0.52. Most recently the company’s share price was $39.72, and it changed around -$0.77 or -1.90% from the last close, which brings the market valuation of the company to $80.53B. GSK currently trades at a discount to its 52-week high of $44.67, offering almost -12.46% off that amount. The share price’s 52-week low was $31.72, which indicates that the current value has risen by an impressive 20.14% since then. We note from GSK Plc ADR’s average daily trading volume that its 10-day average is 4.35 million shares, with the 3-month average coming to 5.32 million.
GSK Plc ADR stock received a consensus recommendation rating of Hold, based on a mean score of 2.91. If we narrow it down even further, the data shows that 1 out of 10 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 5 recommended GSK as a Hold, whereas 2 deemed it a Buy, and 1 rated it as Underweight.
GSK Plc ADR (NYSE:GSK) trade information
Instantly GSK has showed a red trend with a performance of -1.90% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 42.63 on recent trading dayincreased the stock’s daily price by 6.83%. The company’s shares are currently up 17.45% year-to-date, but still down -3.83% over the last five days. On the other hand, GSK Plc ADR (NYSE:GSK) is 5.53% up in the 30-day period. We can see from the shorts that 16.67 million shares have been sold at a short interest cover period of 3.18 day(s).
The consensus price target as assigned by Wall Street analysts is $35.25, which translates to bulls needing to decrease their stock price by -12.68% from its current value. Analyst projections state that GSK is forecast to be at a low of $35.25 and a high of $35.25.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -11.63%. GSK Plc ADR earnings are expected to increase by 10.64% in 2025, but the outlook is positive 9.83% per year for the next five years.
GSK Dividends
GSK Plc ADR’s next quarterly earnings report is expected to be released on 2025-Apr-29. The annual dividend yield of the stock is 4.04 percent and its annual dividend per share was 1.61. It is important to note, however, that the 4.04% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 4.77 per year.
GSK Plc ADR (NYSE:GSK)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.06% of GSK Plc ADR shares, and 18.33% of them are in the hands of institutional investors. The stock currently has a share float of 18.34%. GSK Plc ADR stock is held by 987.0 institutions, with DODGE & COX being the largest institutional investor. By 2024-06-30, it held 1.6753% of the shares, which is about 68.34 million shares worth $2.63 billion.
FMR LLC, with 0.6566% or 26.78 million shares worth $1.03 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
